Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

4D Molecular Therapeutics, Inc.

NASDAQ: FDMT · Life Sciences · 6 alerts · CIK 1650648

Share price
$11.29Close, Nov 16
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All 4D Molecular Therapeutics, Inc. filings on SEC EDGAR ↗

4:56 PM ET Form 4
Insider Selling

4D Molecular Therapeutics CLO Scott Bizily Sells $21K of Stock

Scott Bizily, CLO, sold 1,635 shares of 4D Molecular Therapeutics, Inc. at $12.84 a share, worth $21K in total on Oct 16, 2026. Shares held after the trade: 8,617 (-15.9%).

Value
$21K
Shares
1,635
Price
$12.84
Role
CLO
Holding change
-15.9%
Trade date
Oct 16, 2026
5:12 PM ET Form 4
Insider Selling

4D Molecular Therapeutics Insider David Kirn Sells $750K of Stock

David Kirn sold 58,061 shares of 4D Molecular Therapeutics, Inc. at $12.92 a share, worth $750K in total on Oct 5, 2026. Shares held after the trade: 709,425 (-7.6%).

Value
$750K
Shares
58,061
Price
$12.92
Holding change
-7.6%
Trade date
Oct 5, 2026
5:14 PM ET Form 4
Insider Selling

4D Molecular Therapeutics Insider David Kirn Sells $811K of Stock

David Kirn sold 58,333 shares of 4D Molecular Therapeutics, Inc. at $13.90 a share, worth $811K in total on Sep 14, 2026. Shares held after the trade: 767,486 (-7.1%).

Value
$811K
Shares
58,333
Price
$13.90
Holding change
-7.1%
Trade date
Sep 14, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.